🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
45.14
-2.18 (-4.61%)
Nov 20, 2026, 5:29 PM CET

Hansa Biopharma AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
301.64222.27171.32134.09154.5333.88
Revenue Growth
68.88%29.74%27.76%-13.22%356.12%455.56%
Cost of Revenue
137.2183.5683.5563.1438.4815.43
Gross Profit
164.43138.7187.7670.95116.0518.45
Selling, General & Admin
473.66356.55344.27450.49337.86327.27
Research & Development
265.01304.74375.72411.33346.24230.76
Other Operating Expenses
5.17--0.298.06-
Operating Expenses
743.83661.28719.99862.11692.17558.03
Operating Income
-579.4-522.58-632.22-791.16-576.12-539.58
Interest Expense
-192.36-122.49-134.08-105.52-43.67-0.69
Interest & Investment Income
-7.3320.8328.068.830.07
Currency Exchange Gain (Loss)
29.84165.34-71.3937.815.95-7.4
Other Non Operating Income (Expenses)
-3.49-12.65--4.97-0.53
EBT Excluding Unusual Items
-745.41-472.4-804.21-830.81-609.98-548.13
Merger & Restructuring Charges
-59.45-59.45----
Pretax Income
-783.22-531.84-804.21-830.81-609.98-548.13
Income Tax Expense
2.152.273.030.911.160.15
Net Income
-785.37-534.11-807.24-831.72-611.13-548.28
Net Income to Common
-785.37-534.11-807.24-831.72-611.13-548.28
Net Income Growth
------
Shares Outstanding (Basic)
1028163534544
Shares Outstanding (Diluted)
1028163534544
Shares Change
40.32%29.23%19.59%16.95%1.01%5.45%
EPS (Basic)
-7.71-6.58-12.85-15.83-13.60-12.33
EPS (Diluted)
-7.71-6.58-12.85-15.83-13.60-12.33
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
495.73-549.17-675-755.94-506.06-483.57
Free Cash Flow Per Share
4.87-6.76-10.74-14.39-11.27-10.87
Gross Margin
54.51%62.41%51.23%52.91%75.10%54.47%
Operating Margin
-192.08%-235.11%-369.04%-590.00%-372.83%-1592.71%
Profit Margin
-260.36%-240.30%-471.20%-620.25%-395.49%-1618.40%
Free Cash Flow Margin
164.34%-247.08%-394.01%-563.74%-327.50%-1427.38%
EBITDA
-570.43-520.07-629.67-788.33-573.71-538.06
EBITDA Margin
-189.11%-233.99%----
D&A For EBITDA
8.972.52.552.832.411.52
EBIT
-579.4-522.58-632.22-791.16-576.12-539.58
EBIT Margin
-192.08%-235.11%----